A higher body temperature is associated with haemorrhagic transformation in patients with acute stroke untreated with recombinant tissue-type plasminogen activator (rtPA)

Clinical Science

Volumn 122, Issue 3, 2012, Pages 113-119

  Leira, Rogelio ^a   Sobrino, Tomás ^a   Blanco, Miguel ^a   Campos, Francisco ^a,b   Rodríguez Ýñez, Manuel ^a   Castellanos, Mar ^c   Moldes, Octavio ^a   Millán, Mónica ^d   Dávalos, Antoni ^d   Castillo, JośE ^a  

^a Instituto de Salud Carlos III   (Spain)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

^c HOSPITAL JOSEP TRUETA   (Spain)

^d HOSPITAL UNIVERSITARI GERMANS TRIAS I PUJOL   (Spain)

Author keywords

Biomarkers; Blood brain barrier (BBB); Haemorrhagic transformation (HT); Ischaemic stroke; Temperature

Indexed keywords

ALTEPLASE; FIBRONECTIN; GELATINASE B; BIOLOGICAL MARKER; RECOMBINANT PROTEIN; TISSUE PLASMINOGEN ACTIVATOR;

AGED; ARTICLE; BLOOD BRAIN BARRIER; BODY TEMPERATURE; BRAIN HEMORRHAGE; BRAIN ISCHEMIA; DIFFUSION WEIGHTED IMAGING; ENZYME BLOOD LEVEL; HUMAN; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RISK FACTOR; SCORING SYSTEM; BLOOD; GENETICS; METABOLISM; MIDDLE AGED; PATHOLOGY; PATHOPHYSIOLOGY; STATISTICAL MODEL; STROKE; TIME;

AGED; AGED, 80 AND OVER; BIOLOGICAL MARKERS; BLOOD-BRAIN BARRIER; BODY TEMPERATURE; BRAIN ISCHEMIA; CEREBRAL HEMORRHAGE; FIBRONECTINS; HUMANS; LOGISTIC MODELS; MATRIX METALLOPROTEINASE 9; MIDDLE AGED; RECOMBINANT PROTEINS; STROKE; TIME FACTORS; TISSUE PLASMINOGEN ACTIVATOR;

EID: 84856407223     PISSN: 01435221     EISSN: None     Source Type: Journal    
DOI: 10.1042/CS20110143     Document Type: Article

References (47)

1. Kim, Y., Busto, R., Dietrich, W. D., Kraydieh, S. and Ginsberg, M. D. (1996) Delayed postischemic hyperthermia in awake rats worsens the histopathological outcome of transient focal cerebral ischemia. Stroke 27, 2274-2281
2. Busto, R., Dietrich, W., Globus, M. T., Valdés, I., Scheinberg, P. and Ginsberg, M. D. (1987) Small differences in intraischemic brain temperature critically determine the extent of ischemic neuronal injury. J. Cereb. Blood Flow Metab. 7, 729-738
3. Dietrich, W., Busto, R., Valdés, I. and Loor, Y. (1990) Effects of normothermic versus mild hyperthermic forebrain ischemia in rats. Stroke 21, 1318-1325
4. Morikawa, E., Ginsberg, M. D., Dietrich, W. D., Duncan, R. C., Kraydieh, S., Globus, M. Y. and Busto, R. (1992) The significance of brain temperature in focal cerebral ischemia: histopathological consequences of middle cerebral artery occlusion in the rat. J. Cereb. Blood Flow Metab. 12, 380-389
5. Clifton, G., Jiang, J., Lyeth, B., Jenkins, L., Hamm, R. and Hayes, R. (1991) Marked protection by moderate hypothermia after experimental traumatic brain injury. J. Cereb. Blood Flow Metab. 11, 114-121
6. Baker, C. J., Onesti, S. T. and Solomon, R. A. (1992) Reduction by delayed hypothermia of cerebral infarction following middle cerebral artery occlusion in the rat: a time-course study. J. Neurosurg. 77, 438-444
7. Maher, J. and Hachinski, V. (1993) Hypothermia as a potential treatment for cerebral ischaemia. Cerebrovasc. Brain. Metab. Rev. 5, 277-300
8. Meden, P., Kammersgaard, L. and Overgaard, K. (1998) Can acute stroke be treated with hypothermia? Nord. Med. 113, 3-5
9. Ishikawa, M., Sekisuka, E. and Sato, S. (1999) Effects of moderate hypothermia on leukocyte-endothelium interaction in the rat pial microvasculature after transient middle cerebral artery occlusion. Stroke 30, 1679-1686
10. Globus, M. Y., Alonso, O., Dietrich, W. D., Busto, R. and Ginsberg, M. D. (1995) Glutamate release and free radical production following brain injury: effects of posttraumatic hypothermia. J. Neurochem. 65, 1250-1256
11. Castillo, J., Dávalos, A., Marrugat, J. and Noya, M. (1998) Timing for fever-related brain damage in acute ischemic stroke. Stroke 29, 2455-2460
12. Reith, J., Jorgensen, H., Pedersen, P., Nakayama, H., Raaschou, H., Jeppesen, L. and Olsen, T. (1996) Body temperature in acute stroke: relation to stroke severity, infarct size, mortality, and outcome. Lancet 347, 422-425
13. Hindfelt, B. (1976) The prognosis significance of subfebrility and fever in ischaemic cerebral infarction. Acta Neurol. Scand. 53, 72-79
14. Terent, A. and Andersson, B. (1981) The prognosis for patients with cerebrovascular stroke and transient ischemic attacks. Ups. J. Med. Sci. 86, 63-67
15. Castillo, J., Martínez, F., Leira, R., Prieto, J. M., Lema, M. and Noya, M. (1994) Mortality and morbidity of acute cerebral infarction related to temperature and basal analytic parameters. Cerebrovasc. Dis. 4, 66-71
16. Azzimondi, G., Bassein, L., Nonino, F., Fiorani, L., Vignateli, L., Re, G. and D'Alessandro, R. (1995) Fever in acute stroke worsens prognosis. Stroke 26, 2040-2043
17. Wang, Y., Lim, L. Y., Levi, C., Heller, R. and Fisher, J. (2000) Influence of admission body temperature on stroke mortality. Stroke 31, 404-409
18. Hajat, C., Hajat, S. and Sharma, P. (2000) Effects of stroke pyrexia on stroke outcome. A meta-analysis of studies in patients. Stroke 31, 410-414
19. Toni, D., Fiorelli, M., Bastianello, S., Sacchetti, M. L., Sette, G., Argentino, C., Montinaro, E. and Bozzao, L. (1996) Hemorrhagic transformation of brain infarct: predictability in the first 5 hours from stroke onset and influence on clinical outcome. Neurology 46, 341-345
20. Babikian, V. L., Kase, C. S., Pessin, M. S., Norrving, B. and Gorelick, P. B. (1989) Intracerebral hemorrhage in stroke patients anticoagulated with heparin. Stroke 20, 1500-1503
21. National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group (1995) Tissue plasminogen activator for acute ischemic stroke. N. Engl. J. Med. 333, 1581-1587
22. Larrue, V., von Kummer, R. and del Zoppo, G. (1997) Hemorrhagic transformation in acute ischemic stroke: potential contributing factors in the European Cooperative Acute Stroke Study. Stroke 28, 957-960
23. Levy, D. E., Brott, T. G., Haley, Jr, E. C., Marler, J. R., Sheppard, G. L., Barsan, W. and Broderick, J. P. (1994) Factors related to intracerebral hematoma formation in patients receiving tissue-type plasminogen activator for acute ischemic stroke. Stroke 25, 291-297
24. Brott, T. G., Haley, E. C., Levy, D. E., Barsan, W., Broderick, J., Sheppard, G. L., Spilker, J., Kongable, G. L., Massey, S., Reed, R. et al. (1992) Urgent therapy for stroke, I: pilot study of tissue plasminogen activator administered within 90 minutes. Stroke 23, 632-640
25. Haley, E. C., Levy, D. E., Brott, T. G., Sheppard, G. L., Melvin, C. W.W., Kongable, G. L., Torner, J. C. and Marler, J. R. (1992) Urgent therapy for stroke, II: pilot study of tissue plasminogen activator administered within 91-180 minutes from onset. Stroke 23, 641-645
26. Hammann, G. F., Okada, Y. and del Zoppo, G. J. (1996) Hemorrhagic transformation and microvascular integrity during focal cerebral ischemia/reperfusion. J. Cereb. Blood Flow Metab. 16, 1373-1378
27. Montaner, J., Molina, C. A., Monasterio, J., Abilleira, S., Arenillas, J. F., Ribó, M., Quintana, M. and Alvarez-Sabin, J. (2003) Matrix metalloproteinase-9 pretreatment level predicts intracranial hemorrhagic complications after thrombolysis in human stroke. Circulation 107, 598-603
28. Castellanos, M., Leira, R., Serena, J., Blanco, M., Pedraza, S., Castillo, J. and Davalos, A. (2004) Plasma cellular-fibronectin concentration predicts hemorrhagic transformation after thrombolytic therapy in acute ischemic stroke. Stroke 35, 1671-1676
29. Heo, J. H., Kim, S. H., Lee, K. Y., Kim, E., Chu, C. and Nam, J. M. (2003) Increase in plasma matrix metalloproteinase-9 in acute stroke patients with thrombolysis failure. Stroke 34, 48-50
30. Castellanos, M., Leira, R., Serena, J., Pumar, J. M., Lizasoain, I., Castillo, J. and Davalos, A. (2003) Plasma metalloproteinase-9 concentration predicts hemorrhagic transformation in acute ischemic stroke. Stroke 34, 40-46
31. Montaner, J., Alvarez-Sabin, J., Molina, C. A., Angles, A., Abilleira, S., Arenillas, J. and Monasterio, J. (2001) Matrix metalloproteinase expression is related to hemorrhagic transformation after cardioembolic stroke. Stroke 32, 2762-2767
32. Leira, R., Rodríguez-Yáñez, M., Castellanos, M., Blanco, M., Nombela, F., Sobrino, T., Lizasoain, I., Dávalos, A. and Castillo, J. (2006) Hyperthermia is a surrogate marker of inflammation-mediated cause of brain damage in acute ischaemic stroke. J. Inter. Med. 260, 343-349
33. Adams, H. P., Bendixen, B. H., Kappelle, L. J., Biller, J., Love, B. B., Gordon, D. L. and Marsh, E. E. (1993) Classification of subtype of acute ischemic stroke: definitions for use in a multicenter clinical trial. Stroke 24, 35-41
34. Hacke, W., Kaste, M., Fieschi, C., von Kummer, R., Davalos, A., Meier, D., Larrue, V., Bluhmki, E., Davis, S., Donnan, G. et al. (1998) Randomised double-blind placebo-controlled trial of thrombolytic therapy with intravenous alteplase in acute stroke (ECASS II). Lancet 352, 1245-1251
35. Millán, M., Grau, L., Castellanos, M., Rodríguez-Yáñez, M., Arenillas, J. F., Nombela, F., Pérez de la Ossa, N., López-Manzanares, L., Serena, J., Castillo, J. et al. (2008) Body temperature and response to thrombolytic therapy in acute ischaemic stroke. Eur. J. Neurol. 15, 1384-1389
36. Lin, S., Wu, B., Hao, Z. L., Kong, F. Y., Tao,W. D., Wang, D. R., He, S. and Liu, M. (2011) Characteristics, treatment and outcome of ischemic stroke with atrial fibrillation in a Chinese hospital-based stroke study. Cerebrovasc. Dis. 31, 419-426
37. Tu, H. T., Campbell, B. C., Christensen, S., Collins, M., De Silva, D. A., Butcher, K. S., Parsons, M. W., Desmond, P. M., Barber, P. A., Levi, C. R. et al. (2010) Pathophysiological determinants of worse stroke outcome in atrial fibrillation. Cerebrovasc. Dis. 30, 389-395
38. Paciaroni, M., Agnelli, G., Corea, F., Ageno, W., Alberti, A., Lanari, A., Caso, V., Micheli, S., Bertolani, L., Venti, M. et al. (2008) Early hemorrhagic transformation of brain infarction: rate, predictive factors, and influence on clinical outcome: results of a prospective multicenter study. Stroke 39, 2249-2256
39. Rodríguez-Yáñez, M., Castellanos, M., Blanco, M., Millán, M., Nombela, F., Sobrino, T., Lizasoain, I., Leira, R., Serena, J., Dávalos, A. et al. (2006) Micro- and macroalbuminuria predict hemorrhagic transformation in acute ischemic stroke. Neurology 67, 1172-1177
40. Hammann, G. F., del Zoppo, G. J. and von Kummer, R. (1999) Hemorrhagic transformation of cerebral infarction-possible mechanisms. Thromb. Haemostasis 82(Suppl. 1), 92-94
41. Urakawa, M., Yamaguchi, K., Tsuchida, E., Kashiwagi, S., Ito, H. and Matsuda, T. (1995) Blood-brain disturbance following localized hyperthermia in rats. Int. J. Hyperthermia 11, 709-718
42. Oztas, B. and Kucuk, M. (1998) Reversible blood-brain barrier dysfunction after intracarotid hyperthermic saline infusion. Int. J. Hyperthermia 14, 395-401
43. Ikeda, T., Xia, X. Y., Xia, Y. X. and Ikenoue, T. (1999) Hyperthermic preconditionating prevents blood-brain barrier disruption produced by hypoxia-ischemia in newborn rat. Brain Res. Dev. Brain Res. 117, 53-58
44. Noor, R., Xu, C.W. and Shuaib, A. (2005) Hyperthermia masks the neuroprotective effects of tissue plasminogen activator. Stroke 36, 665-669
45. Heo, J. H., Lucero, J., Abumiya, T., Koziol, J. A., Copeland, B. R. and del Zoppo, G. J. (1999) Matrix metalloproteinases increase very early during experimental focal cerebral ischemia. J. Cereb. Blood Flow Metab. 19, 624-633
46. Rosenberg, G. A., Mun-Bryce, S., Wesley, M. and Kornfeld, M. (1990) Collagenase-induced intracerebral hemorrhage in rats. Stroke 21, 801-807
47. Lee, J. E., Yoon, Y. J., Moseley, M. E. and Yenari, M. A. (2005) Reduction in levels of matrix metalloproteinases and increased expression of tissue inhibitor of metalloproteinase-2 in response to mild hypothermia therapy in experimental stroke. J. Neurosurg. 103, 289-297